Instituto de Assistência Médica ao Servidor Público Estadual
- World rank, 2022–2025
- #27,944 of 28,054 · #42,153 all time
- Rank in ??
- #674 of 692
- Research works
- 147 ▲ 243% vs 2013–17
- Citations
- 784 5.3 per fractional work
- Top-10% rate
- 1.1% record average 16.5%
- Open access
- 87% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.
- Medicine 4.1×
- Immunology and Microbiology 4.1×
- Health Professions 1.6×
- Dentistry 1.1×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Veterinary 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Social Sciences 0.3×
- Computer Science 0.2×
- Neuroscience 0.1×
- Nursing 0.1×
- Business, Management and Accounting 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
- Engineering 0.0×
- Agricultural and Biological Sciences 0.0×
Which keywords describe research at Instituto de Assistência Médica ao Servidor Público Estadual?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Prognostic Factors, Rituximab, Hematopoietic Stem Cells, Pathophysiology, Chronic Lymphocytic Leukemia, Genomic Aberrations and Treatment.
- Clinical Characteristics
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Social Determinants
- Laparoscopic Surgery
- Hodgkin's Lymphoma
- Genetic Pathogenesis
- Genetic Mutations
- Molecular Profiling
- Surgical Management
- Autoantibodies
- Minimal Residual Disease
- Lymphoma
- Complications
- AML
- Genomic Aberrations
- Pathophysiology
- Diagnosis
- Inflammation
- Prognostic Factors
- Epidemiology
- Rituximab
- Treatment
- Hematopoietic Stem Cells
- Chronic Lymphocytic Leukemia
- Quality of Life
- Acute Myeloid Leukemia
- Immune Response
- Public Health
- PET Imaging
- Rehabilitation
- Classification
- Radiotherapy
- Immunotherapy
- Healthcare Access
- Clinical Practice Guidelines
- SARS-CoV-2
- ACE2 Receptor
- Cancer Incidence
- Genetic Alterations
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology11▲ 4.6×50 topics
- Prognostic Factors6▲ 23×9 topics
- Rituximab4▲ 42×3 topics
- Inflammation3▲ 2.6×17 topics
- Treatment3▲ 4.1×20 topics
- Diagnosis3▲ 4.6×17 topics
- Hematopoietic Stem Cells2▲ 48×2 topics
- Pathophysiology2▲ 13×5 topics
- Chronic Lymphocytic Leukemia2▲ 82×1 topic
- Genomic Aberrations2▲ 82×1 topic
- Quality of Life2▲ 2.5×11 topics
- AML2▲ 71×1 topic
- Acute Myeloid Leukemia2▲ 71×1 topic
- Complications2▲ 6.9×11 topics
- Immune Response2▲ 6.0×6 topics
- Lymphoma2▲ 20×4 topics
- Public Health2▲ 2.2×8 topics
- Minimal Residual Disease2▲ 44×2 topics
- PET Imaging2▲ 18×3 topics
- Autoantibodies2▲ 12×5 topics
- Rehabilitation2▲ 7.1×6 topics
- Surgical Management2▲ 6.9×7 topics
- Classification2▲ 5.7×2 topics
- Molecular Profiling2▲ 26×2 topics
- Radiotherapy2▲ 6.9×8 topics
- Genetic Mutations2▲ 5.8×7 topics
- Immunotherapy2▲ 3.5×9 topics
- Genetic Pathogenesis1▲ 43×1 topic
- Healthcare Access1▲ 8.4×3 topics
- Hodgkin's Lymphoma1▲ 43×1 topic
- Clinical Practice Guidelines1▲ 4.1×7 topics
- Laparoscopic Surgery1▲ 19×2 topics
- SARS-CoV-21▲ 6.4×3 topics
- Social Determinants1▲ 10×3 topics
- ACE2 Receptor1▲ 7.8×2 topics
- Acute Lymphoblastic Leukemia1▲ 53×1 topic
- Cancer Incidence1▲ 14×4 topics
- Childhood Cancer1▲ 53×1 topic
- Genetic Alterations1▲ 24×2 topics
- Clinical Characteristics1▲ 13×2 topics
Which research topics does Instituto de Assistência Médica ao Servidor Público Estadual publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Acute Lymphoblastic Leukemia research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 2 works
- 2 Acute Myeloid Leukemia Research Hematology 2 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 6 Healthcare during COVID-19 Pandemic Information Systems 1 works
- 7 Public Health in Brazil Sociology and Political Science 1 works
- 8 Immunodeficiency and Autoimmune Disorders Immunology 1 works
- 9 Multiple Myeloma Research and Treatments Hematology 1 works
- 10 Intestinal and Peritoneal Adhesions Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto de Assistência Médica ao Servidor Público Estadual's research output changed?
Output in 2018–2022 was 243% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in São Paulo
- Instituto de Estudos Avançados da Universidade de São Paulo
- Escola de Economia de São Paulo
- Faculdade de Tecnologia de São Paulo
- Centro Universitário das Américas (FAM) - São Paulo
- CETESB - Companhia Ambiental do Estado de São Paulo
- ICTP South American Institute for Fundamental Research
- CEJAM - Centro de Estudos e Pesquisas Dr João Amorim
- Fundação Lemann
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.